Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis

Hepatology

Volumn 29, Issue 3, 1999, Pages 644-647

  Angulo, Paul ^a   Batts, Kenneth P ^a   Therneau, Terry M ^a   Jorgensen, Roberta A ^a   Rolland Dickson, E ^a   Lindor, Keith D ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLAMINE; PLACEBO; URSODEOXYCHOLIC ACID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; LONG TERM CARE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL;

EID: 0032979123     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290301     Document Type: Article

References (13)

1. Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1996;335:1570-1580.
2. Angulo P, Lindor KD. Management of primary biliary cirrhosis and autoimmune cholangitis. Clin Liver Dis 1998;2:333-351.
3. Poupon RE, Balkau B, Eschwege E, Poupon R, and the UDCA-PBC study group. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. N Engl J Med 1991;324:1548-1554.
4. Poupon RE, Poupon R, Balkau B, and the UDCA-PBC study group. Ursodiol for the long-term treatment of primary biliary cirrhosis. N Engl J Med 1994;330:1342-1347.
5. Lindor KD, Dickson ER, Baldus WP, Jorgensen RA, Ludwig J, Murtaugh PA, Harrison JM, et al. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 1994;106:1284-1290.
6. Lindor KD, Therneau TM, Jorgensen RA, Malinchoc M, Dickson ER. Effects of ursodeoxycholic acid on survival on patients with primary biliary cirrhosis. Gastroenterology 1996;1110:1515-1518.
7. Heathcote EJ, Cauch-Dudek K, Walker V, Bailey RJ, Blendis LM, Ghent CN, Mitchieletti P, et al. The Canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. HEPATOLOGY 1994;19:1149-1156.
8. Combes B, Carithers RL Jr, Maddrey WC, Lin D, McDonald MF, Wheeler DE, Eigenbrodt EH, et al. A randomized double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. HEPATOLOGY 1995;22:759-766.
9. Emmond E, Carithers RL Jr, Luketic VA, Peters M, Zetterman RK, Garcia-Tsao G, Munoz SJ, et al. Does ursodeoxycholic acid improve survival in patients with primary biliary cirrhosis? Comparison of outcome in the U.S. multicenter trial to expected survival using the Mayo Clinic prognostic model [Abstract]. HEPATOLOGY 1996;24:168A.
10. Poupon RE, Lindor KD, Cauch-Dudek K, Dickson ER, Poupon R, Heathcote EJ. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 1997;113:884-890.
11. Lindor KD, Jorgensen RA, Therneau TM, Malinchoc M, Dickson ER. Ursodeoxycholic acid delays the onset of esophageal varices in primary biliary cirrhosis. Mayo Clin Proc 1997;72:1137-1140.
12. Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A. Prognosis in primary biliary cirrhosis: model for decision making. HEPATOLOGY 1989;97:10:1-7.
13. Kilmurry MR, Heathcote EJ, Cauch-Dudek K, O'Rourke K, Bailey RJ, Blendis LM, Ghent CN, et al. Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis? HEPATOLOGY 1996;23:1148-1153.